Dems Side With FDA On Generic Drug Labeling Overhaul
In a letter to FDA Commissioner Margaret Hamburg, 41 Democrats from both the House and Senate said that current rules preventing generic drugmakers from updating labels without prior FDA approval negatively impact their constituents.
Among the lawmakers signing the letter were Sens. Patrick Leahy, D-Vt., and Tom Harkin, D-Iowa, and Reps. Henry Waxman,...
To view the full article, register now.